Evidence map›Paper›PMID 36192547›Full record

Observational studyEuropean journal of pediatrics2022

Increased rate of respiratory symptoms in children with Down syndrome: a 2-year web-based parent-reported prospective study.

Noortje B Eijsvoogel, Ruud H J Verstegen, Gijs Th J van Well, Roeland W N M van Hout, Esther de Vries

Open access · hybridAbstract readObservational Study
In one paragraph

Observational study in European journal of pediatrics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Noortje B EijsvoogelTranzo Tilburg School of Social and Behavioral Sciences, Tilburg University, PO Box 90153 (RP219), 5000LE, Tilburg, the Netherlands.
Ruud H J VerstegenDivision of Clinical Pharmacology and Toxicology, Department of Pediatrics, The Hospital for Sick Children, Toronto, ON, Canada.
Gijs Th J van WellDepartment of Pediatrics, Maastricht University Medical Center, Maastricht, the Netherlands.
Roeland W N M van HoutCentre for Language Studies, Radboud University, Nijmegen, the Netherlands.
Esther de VriesTranzo Tilburg School of Social and Behavioral Sciences, Tilburg University, PO Box 90153 (RP219), 5000LE, Tilburg, the Netherlands. e.devries@tilburguniversity.edu.ORCID http://orcid.org/0000-0003-4311-3550
Tilburg University · NLMaastricht University · NLRadboud University Nijmegen · NLUniversity of Toronto · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To compare the incidence of respiratory symptoms and short-term consequences between children with Down syndrome and children from the general population, we conducted a prospective parent-reported observational study. Children with Down syndrome (≤ 18 years) were included between March 2012 and June 2014. Caregivers received a baseline questionnaire with follow-up 1-2 years after inclusion. Caregivers received a weekly questionnaire about respiratory symptoms, fever, antibiotic prescriptions, doctor's visits, and consequences for school and work attendance. Children with Down syndrome were compared to a cohort of the general population ("Kind en Ziek" study) with similar weekly questionnaires. A total of 9,011 childweeks were reported for 116 participants with Down syndrome (75% response rate). The frequency of respiratory symptoms was higher in children with Down syndrome than in children from the general population (30% vs 15.2%). In addition, symptoms subsided later (around 8 vs 5 years of age). The seasonal influence was limited, both in children with Down syndrome and children from the general population. Consequences of respiratory disease were significant in children with Down syndrome compared to children from the general population, with a higher rate of doctor's visits (21.3% vs 11.8%), antibiotic prescriptions (47.8% vs 26.3%), and absenteeism from school (55.5% vs 25.4%) and work (parents, 9.4% vs 8.1%).  Conclusion: Children with Down syndrome have a higher frequency of respiratory symptoms and symptoms last until a later age, confirming the impression of professionals and caregivers. Individualized treatment plans might prevent unfavorable consequences of chronic recurrent respiratory disease in children with Down syndrome. What is Known: • Children with Down syndrome have an altered immune system and are prone to a more severe course of respiratory tract infections. • The overall conception is that patients with Down syndrome suffer from respiratory tract infections more often. What is New: • Children with Down syndrome suffer from respiratory symptoms more frequently than children from the general population. • The respiratory symptoms in children with Down syndrome subside at a later age compared to children from the general population.

Indexed as

Down SyndromeRespiratory Tract InfectionsAnti-Bacterial AgentsChildHumansInternetParentsProspective StudiesAnti-Bacterial AgentsDown syndromeFrequency of respiratory symptomsParental questionnaireSeasonal influenceType of respiratory symptoms

Identifiers

PMID36192547
PMCPMC9649482
OpenAlexW4300818095

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.